Samsara Therapeutics
PrivateLast Round
Grant
Oct 28, 2024
Total Funding Raised
$29.1M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Samsara Therapeutics is a biotechnology company that develops small-molecule autophagy activators to treat age-related neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Samsara Therapeutics Comparables
Compare Samsara Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Casma Therapeutics | 91% | |
| Libra Therapeutics | 88% | |
| PAQ Therapeutics | 88% | |
Samsara Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 28, 2024 | ||||
| Grant | Nov 1, 2023 | ||||
| Grant | Jun 12, 2023 | ||||
| Grant | Oct 12, 2022 | ||||
| Seed | Dec 20, 2019 |
Samsara Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Grant |
| Innovate UK | Grant |
| Target ALS | Grant |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Kite Ventures | Seed |
| CMT Research Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 1170% MoM, reaching 2.6K.
- Jun 12, 2023
Received funding from The ALS Association and The Michael J. Fox Foundation.
Samsara Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Samsara Therapeutics's valuation, stock price, and market status.